Table 1 Characteristics of MM patients... | American Society of Hematology

Table 1

Characteristics of MM patients

Patient no.	MM stage	MM status	Bone disease	Treatment
Patient no.	MM stage	MM status	Bone disease	Current	Prior	Bisphosphonate
1	III	Newly diagnosed	Yes	None	None	None
2	III	Newly diagnosed	Yes	None	None	None
3	III	Newly diagnosed	Yes	None	None	None
4	III	Newly diagnosed	Yes	None	None	None
5	IIIB	Newly diagnosed	Yes	None	None	None
6	III	Newly diagnosed	Yes	None	None	Zol (prior)
7	I	Newly diagnosed	No	None	None	None
8	III	In remission	Yes	None	Mel, Thal, Pred	None
9	III	Partial remission	Yes	None	Len, Thal, Dex	Zol (prior)
10	III	Relapsed	Yes	None; but received Cytoxan recently	Thal, Dex	Zol
11	III	Relapsed	Yes	None	Mel, Bort, Thal, Dex	None
12	III	Relapsed	Yes	None	Bend, Bort, Len, Pom; Autologous BMT ×2	None
13	IIIB	Relapsed	Yes	None	Len, Dex	Zol
14	III	Relapsed	Yes	None	Bort	Pam
15	III	Relapsed	Yes	Len, Bend, Dex	Bort, Len, Dex	Pam
16	III	Relapsed	Yes	Len, Bend, Dex	Len, Thal; ASCT	Zol

Patient no.	MM stage	MM status	Bone disease	Treatment
Patient no.	MM stage	MM status	Bone disease	Current	Prior	Bisphosphonate
1	III	Newly diagnosed	Yes	None	None	None
2	III	Newly diagnosed	Yes	None	None	None
3	III	Newly diagnosed	Yes	None	None	None
4	III	Newly diagnosed	Yes	None	None	None
5	IIIB	Newly diagnosed	Yes	None	None	None
6	III	Newly diagnosed	Yes	None	None	Zol (prior)
7	I	Newly diagnosed	No	None	None	None
8	III	In remission	Yes	None	Mel, Thal, Pred	None
9	III	Partial remission	Yes	None	Len, Thal, Dex	Zol (prior)
10	III	Relapsed	Yes	None; but received Cytoxan recently	Thal, Dex	Zol
11	III	Relapsed	Yes	None	Mel, Bort, Thal, Dex	None
12	III	Relapsed	Yes	None	Bend, Bort, Len, Pom; Autologous BMT ×2	None
13	IIIB	Relapsed	Yes	None	Len, Dex	Zol
14	III	Relapsed	Yes	None	Bort	Pam
15	III	Relapsed	Yes	Len, Bend, Dex	Bort, Len, Dex	Pam
16	III	Relapsed	Yes	Len, Bend, Dex	Len, Thal; ASCT	Zol

Bend indicates bendamustine; Bort, bortezomib; Dex, dexamethasone; Len, lenalidomide; Mel, melphalan; Pam, pamidronate; Pom, pomalidomide; Thal, thalidomide; Zol, zoledronic acid; BMT, bone marrow transplant; and ASCT, autologous stem cell transplant.

View Large

This Feature Is Available To Subscribers Only